New York City, NY -- (SBWIRE) -- 08/19/2013 -- StockMarketIntel.com issues a special report on the following stocks: Soligenix Inc (OTCBB:SNGX), Pulse Beverage Corp (OTCMKTS:PLSB), PURE Bioscience (OTCMKTS:PURE), TNI BIOTECH INC (OTCMKTS:TNIB)
Soligenix Inc (OTCBB:SNGX) gained 1.92%, trading on 110,093 shares, to end the trade at $1.59. The stock changed hands in a range of $1.50 to $1.60, bringing its market capitalization to about $30.26 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.30 and was moved to the maximum level of $2.13. Soligenix, Inc. (SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced its financial results for the quarter and six months ended June 30, 2013.
For How Long SNGX Gloss will Attract Investors? Find out via this report
Pulse Beverage Corp (OTCMKTS:PLSB) declined -2.34%, to complete the trading session at $0.918, with a total volume of 190,416 shares. The stock, on average, trades on a volume of 59,375 shares. It floated in a range of $0.85 to $0.94 during the last trading session, with a beta value of -24.81. Its market capitalization now moved to about $47.24 million. In the past 52 weeks, the share price has not declined below $0.45 and above $1.48. The Pulse Beverage Corporation (PLSB) ("Pulse"), makers of PULSE® brand of functional beverages and Natural Cabana® Lemonade, announce its second quarter financial results for 2013 ("Q2-2013") and issued a corporate update
Has PLSB Found The Bottom and Ready To Move Up? Find Out Here
PURE Bioscience (OTCMKTS:PURE) added 5.56% and was in a range of $0.80-$0.95before closing at $0.950. The stock completed the day with a total volume of 183,846 shares, versus an average volume of 82,283 shares. The share price hit its 52-week low of $0.22 and $3.57 was the best price. PURE Bioscience (PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced a leadership reorganization beginning with the return of Dave Pfanzelter as chairman of the board of directors. Mr. Pfanzelter will also serve as interim chief executive officer while the company initiates the process of recruiting a new CEO.
For How Long PURE will fight for Profitability? R ead This Trend Analysis report
TNI BIOTECH INC (OTCMKTS:TNIB) declined -3.66%, bringing its market capitalization around $112.46 million. The share price, after opening at $1.85, made a high of $1.90 and hovered above $1.67 to end the day at $1.84. The total number of shares that changed hands during the session was 82,835 shares, as compared to average trading volume of 30,066 shares. TNI BioTech, Inc., a specialty pharmaceutical company, focuses on developing and commercializing therapeutic products for the treatment of cancer, HIV/AIDS, hospitalization related, and infectious diseases in the United States and internationally. The company offers IRT-101, an active immunotherapy systemic administration of methionine-enkephalin that works by activating a patient's immune system against infectious diseases and tumor cells.
Has TNIB Found The Bottom And Ready To Gain Momentum? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)